<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[daily mail and glaxosmithkline plc. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/daily+mail+and+glaxosmithkline+plc..html?i=11]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to daily mail and glaxosmithkline plc.]]></description>
	<s:counts start="0" returned="10" found="27" />
	<language>en-us</language>
	<item>
		<title><![CDATA[US litigation, British guidelines hit GlaxoSmithKline finances.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200412/ai_n22285539]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 07 Dec 2004 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[finance]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline's drug development pipeline gives investors cheer.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200411/ai_n22278580]]></link>
		<description><![CDATA[By Ian Lyall, Daily Mail, London Knight Ridder/Tribune Business  News    By Ian Lyall, Daily Mail, London Knight Ridder/Tribune Business  News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 24 Nov 2004 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[Pulses race, shares rise over 2 new drugs in GlaxoSmithkline pipeline.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200411/ai_n22264095]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 02 Nov 2004 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline's CEO isn't depressed by UK drugmaker's profit slide.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200410/ai_n22262316]]></link>
		<description><![CDATA[By Ruth Sunderland, Daily Mail, London Knight Ridder/Tribune  Business News    By Ruth Sunderland, Daily Mail, London Knight Ridder/Tribune  Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 29 Oct 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline move sparks animal rights fears.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200410/ai_n22249842]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 09 Oct 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline is caught in Seroxat crossfire.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200409/ai_n22246024]]></link>
		<description><![CDATA[By Ian Lyall, Daily Mail, London Knight Ridder/Tribune Business  News    By Ian Lyall, Daily Mail, London Knight Ridder/Tribune Business  News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 30 Sep 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline faces US court action over anti-depressant.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200409/ai_n22230946]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 07 Sep 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[AIDS group accuses GlaxoSmithKline of fraud in the United States.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200409/ai_n22228643]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 03 Sep 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline's Anxiety Grows over Controversial Drug.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200406/ai_n22187138]]></link>
		<description><![CDATA[By Stephanie Bentley, Daily Mail, London Knight Ridder/Tribune  Business News    By Stephanie Bentley, Daily Mail, London Knight Ridder/Tribune  Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 15 Jun 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline Agrees to Release Details on Anti-Depression Drug.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200406/ai_n22184884]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 11 Jun 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
</channel>
</rss>
